Company profile for Verséa Ophthalmics

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Verséa Health, Inc. is a transformative healthcare company committed to delivering innovative, high-value diagnostic and therapeutic point-of-care (POC), over-the-counter (OTC), and lab-based solutions across a broad range of diseases. Verséa Health takes a proactive approach in our current reactive healthcare system. Founded in Q4 2018 by Sean Fetcho and Steve Porada the company is led by experienced C-suite executives with...
Verséa Health, Inc. is a transformative healthcare company committed to delivering innovative, high-value diagnostic and therapeutic point-of-care (POC), over-the-counter (OTC), and lab-based solutions across a broad range of diseases. Verséa Health takes a proactive approach in our current reactive healthcare system. Founded in Q4 2018 by Sean Fetcho and Steve Porada the company is led by experienced C-suite executives with growth and acquisition experience across multiple market segments and distribution channels.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
401 S. Florida Ave, Tampa, FL 33602
Telephone
Telephone
+1 8003970670
youtube
YouTube

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

AMWC Asia-TDAC

AMWC Asia-TDAC

Not Confirmed

envelop Contact Supplier

AMWC Asia-TDAC

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.businesswire.com/news/home/20240822574479/en

BUSINESSWIRE
22 Aug 2024

https://www.businesswire.com/news/home/20240606885864/en

BUSINESSWIRE
06 Jun 2024

https://www.globenewswire.com/news-release/2023/07/27/2712254/0/en/Celularity-and-Vers%C3%A9a-Ophthalmics-Announce-Exclusive-U-S-Commercialization-Agreement-to-Distribute-Biovance-and-Biovance-3l-Ocular-For-Ophthalmic-Applications.html

GLOBENEWSWIRE
27 Jul 2023

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty